These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8371515)

  • 21. Pepsinogens, pepsins, and peptic ulcer.
    Samloff IM; Taggart RT
    Clin Invest Med; 1987 May; 10(3):215-21. PubMed ID: 3113799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ecabet disodium, a novel locally-acting antiulcer drug, on epithelial restitution following injury by hypertonic NaCl in bullfrog stomach in vitro.
    Furukawa O; Kume E; Sugamoto S; Kawauchi S; Takeuchi K
    Digestion; 2000; 62(2-3):116-25. PubMed ID: 11025359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of tripotassium dicitrato bismuthate on pepsin activity.
    De Beaux AC; Defize J; Hunt RH
    Aliment Pharmacol Ther; 1989 Aug; 3(4):381-5. PubMed ID: 2518852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pepsin 5 in gastric juice: determination and relationship to the alkali-stable peptic activity.
    Walker V; Taylor WH
    Gut; 1979 Nov; 20(11):977-82. PubMed ID: 43273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the anti-ulcer agents ecabet sodium, cimetidine and sucralfate on acetylsalicylic acid-induced gastric mucosal damage deteriorated by renal failure in rats.
    Nogi K; Taniguchi H; Onoda Y
    Arzneimittelforschung; 2002; 52(11):828-32. PubMed ID: 12489254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid.
    Henman FD
    Gut; 1970 Apr; 11(4):344-51. PubMed ID: 4913800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats.
    Nagahama K; Yamato M; Nishio H; Takeuchi K
    Dig Dis Sci; 2006 Feb; 51(2):303-9. PubMed ID: 16534673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.
    Borella LE; Seethaler K; Lippmann W
    Arzneimittelforschung; 1979; 29(5):793-8. PubMed ID: 387045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ecabet sodium, an antiulcer drug, on gastric adaptive relaxation in isolated guinea-pig stomachs.
    Higuchi K; Tominaga K; Uno H; Yasuda M; Hashiume M; Matsumoto M; Watanabe T; Fujiwara Y; Oshitani N; Matsumoto T; Arakawa T
    Drugs Exp Clin Res; 2002; 28(2-3):105-11. PubMed ID: 12224376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ethanol on peptic activity in the rat stomach.
    Puurunen J
    Digestion; 1982; 23(2):97-103. PubMed ID: 6807734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A kinetic study of protein binding to ecabet sodium using quartz-crystal microbalance.
    Kawakami K; Yasuda M; Ishii K; Kokusenya Y; Sato T
    Chem Pharm Bull (Tokyo); 1999 Jul; 47(7):919-22. PubMed ID: 10434394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative pepstatin inhibition studies on individual human pepsins and pepsinogens 1,3 and 5(gastricsin) and pig pepsin A.
    Roberts NB; Taylor WH
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):209-17. PubMed ID: 14506911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobacter pylori: a prospective, controlled study versus ranitidine.
    Koizumi W; Tanabe S; Imaizumi H; Kida M; Ohida M; Koshida Y; Mitomi H; Hosaka Y; Nagaba S; Sasaki T; Higuchi K; Saigenji K
    Hepatogastroenterology; 2003; 50(50):577-81. PubMed ID: 12749277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of ecabet sodium, an antiulcer drug, on dextran sodium sulfate-induced ulcerative colitis in rats.
    Noto T; Yamada H; Inui T; Okuyama K; Watanable A; Kimura I; Nagasaki M
    Dig Dis Sci; 2005 May; 50(5):922-7. PubMed ID: 15906769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ecabet sodium inhibits Helicobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gastric mucosal cells.
    Kusumoto K; Kawahara T; Kuwano Y; Teshima-Kondo S; Morita K; Kishi K; Rokutan K
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G300-7. PubMed ID: 15458921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pepsins and the mucus barrier in peptic ulcer disease.
    Allen A; Pearson JP; Blackburn A; Coan RM; Hutton DA; Mall AS
    Scand J Gastroenterol Suppl; 1988; 146():50-7. PubMed ID: 3147508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.
    Samloff IM
    Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of sucralfate and its components on acid- and pepsin-induced damage to rat gastric epithelial cells.
    Furukawa O; Matsui H; Suzuki N
    Jpn J Pharmacol; 1997 Sep; 75(1):21-5. PubMed ID: 9334882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
    Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
    Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ecabet sodium].
    Takahashi S; Tanaka A
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():711-6. PubMed ID: 11979876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.